Your session is about to expire
← Back to Search
Procedure
SWAN Therapy for Vestibular Disorders (SWAN Trial)
N/A
Recruiting
Led By Matthew Stewart, MD PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
Stated willingness to comply with all study procedures and availability for the duration of the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily for up to 4 weeks
Awards & highlights
SWAN Trial Summary
This trial tested a self-help tool to help people who have dizziness from a medical condition recover balance & reduce motion sickness.
Who is the study for?
This trial is for people in good health or with unilateral vestibular schwannoma, who can follow the SWAN/vestibular rehab regimen and commit to the study's duration. It excludes those on anti-nausea meds, recent motion sickness treatments, legally blind individuals, or those with neck/spine issues limiting head movement.Check my eligibility
What is being tested?
The trial tests a self-help tool called SWAN against traditional therapy. It aims to reduce motion sickness and improve balance after certain surgeries by training users to gradually increase head movements.See study design
What are the potential side effects?
While specific side effects are not listed, this type of physical rehabilitation may cause temporary discomfort, dizziness or nausea as participants adjust their head movements during exercises.
SWAN Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am generally healthy or have a unilateral vestibular schwannoma.
Select...
I am willing and able to follow the study rules and attend all appointments.
Select...
I am generally healthy or have a unilateral vestibular schwannoma.
Select...
I am willing to follow a specific balance or dizziness treatment plan.
SWAN Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ daily for up to 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily for up to 4 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Motion sickness intensity as assessed by subjective rating
Secondary outcome measures
Change in Daily Activity as assessed by an activity monitor
Change in Foam Stance - Eyes Closed
Change in Foam Stance - Eyes Closed with head motion
+12 moreSWAN Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: SWAN VPT JHUExperimental Treatment1 Intervention
Subjects that have had their eighth cranial nerve resected will receive the automated vestibular rehabilitation method
Group II: SWAN Motion Sick DaytonExperimental Treatment1 Intervention
Healthy control subjects that meet similar similar physical characteristics of astronauts will receive the automated vestibular rehabilitation method post motion sickness.
Group III: Traditional VPT JHUActive Control1 Intervention
Subjects that have had their eighth cranial nerve resected will receive traditional vestibular rehabilitation exercises at Johns Hopkins University (JHU) site.
Group IV: Traditional Motion Sick DaytonActive Control1 Intervention
Typically, the suggestion for treating motion sickness once it has started is to avoid motion. Therefore, healthy control subjects that meet similar similar physical characteristics of astronauts will not receive any post motion sickness treatment.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,259 Previous Clinical Trials
14,820,605 Total Patients Enrolled
National Aeronautics and Space Administration (NASA)FED
24 Previous Clinical Trials
1,718 Total Patients Enrolled
2 Trials studying Motion Sickness
110 Patients Enrolled for Motion Sickness
Matthew Stewart, MD PhDPrincipal InvestigatorJohns Hopkins University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to follow a specific balance or dizziness treatment plan.I cannot walk or stand on my own due to a recent surgery or bone condition.I haven't used any experimental drugs or methods for motion sickness in the last 30 days.I am generally healthy or have a unilateral vestibular schwannoma.I am willing and able to follow the study rules and attend all appointments.I am currently taking medication for nausea.I am generally healthy or have a unilateral vestibular schwannoma.You are willing to comply with all study procedures and are available for the duration of the study.I am willing to follow a specific balance and dizziness exercise program.You have very poor vision, worse than 20/200.I have a neck condition that limits my head movement.
Research Study Groups:
This trial has the following groups:- Group 1: Traditional VPT JHU
- Group 2: SWAN VPT JHU
- Group 3: SWAN Motion Sick Dayton
- Group 4: Traditional Motion Sick Dayton
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Motion Sickness Patient Testimony for trial: Trial Name: NCT05622344 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the eligibility for this research limited to individuals over the age of fifty?
"Those wishing to join this trial must be between 21 and 70 years of age. For those minors under 18, there are 9 separate trials available while 45 other studies exist for patients over 65."
Answered by AI
What is the current patient count for this clinical investigation?
"Affirmative. Details hosted on clinicaltrials.gov demonstrate that this medical experiment, first posted on August 8th 2022, is presently recruiting participants. Approximately 48 research subjects are needed from 2 distinct locations."
Answered by AI
Are there any vacancies left in this medical experiment?
"Affirmative. Information from clinicaltrials.gov reveals that this research is presently looking for volunteers, with the initial posting date of August 8th 2022 and most recent update on November 11th 2022. The trial requires 48 patients at 2 distinct sites to be enrolled in it."
Answered by AI
Is it possible to participate in this clinical investigation?
"This medical trial seeks 48 volunteers aged between 21 and 70 who experience airsickness. Participants must also provide a signed informed consent form, be in good health or have been diagnosed with unilateral vestibular schwannoma, agree to comply with the SWAN and/or rehabilitation regimen specified by the study team, and commit to participating throughout the entirety of the experiment."
Answered by AI
Who else is applying?
What state do they live in?
Maryland
What site did they apply to?
Johns Hopkins University
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
Because I want to help with medical studies to better help everyone get healthy. and I also want the money.
PatientReceived no prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger